PubMed

Joint contractures in the absence of inflammation may indicate mucopolysaccharidosis.

Cimaz R, Coppa GV, Koné-Paut I, Link B, Pastores GM, Elorduy MR, Spencer C, Thorne C, Wulffraat N, Manger B.

Pediatr Rheumatol Online J. 2009 Oct 23;7:18.PMID: 19852785 [PubMed - in process]Related articlesFree article

Attenuated type I mucopolysaccharidosis in the differential diagnosis of juvenile idiopathic arthritis: a series of 13 patients with Scheie syndrome.

Cimaz R, Vijay S, Haase C, Coppa GV, Bruni S, Wraith E, Guffon N.

Clin Exp Rheumatol. 2006 Mar-Apr;24(2):196-202.PMID: 16762159 [PubMed - indexed for MEDLINE]Related articles

Galsulfase: arylsulfatase B, BM 102, recombinant human arylsulfatase B, recombinant human N-acetylgalactosamine-4-sulfatase, rhASB.

[No authors listed]

Drugs R D. 2005;6(5):312-5. Review.PMID: 16128602 [PubMed - indexed for MEDLINE]Related articles

The MPS I registry: design, methodology, and early findings of a global disease registry for monitoring patients with Mucopolysaccharidosis Type I.

Pastores GM, Arn P, Beck M, Clarke JT, Guffon N, Kaplan P, Muenzer J, Norato DY, Shapiro E, Thomas J, Viskochil D, Wraith JE.

Mol Genet Metab. 2007 May;91(1):37-47. Epub 2007 Mar 2.PMID: 17336562 [PubMed - indexed for MEDLINE]Related articles

The first 5 years of clinical experience with laronidase enzyme replacement therapy for mucopolysaccharidosis I.

Wraith JE.

Expert Opin Pharmacother. 2005 Mar;6(3):489-506. Review.PMID: 15794739 [PubMed - indexed for MEDLINE]Related articles

Enzyme replacement therapy with idursulfase in patients with mucopolysaccharidosis type II.

Wraith JE.

Acta Paediatr Suppl. 2008 Apr;97(457):76-8. Review.PMID: 18339193 [PubMed - indexed for MEDLINE]Related articles

A systematic review of new advances in the management of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): focus on galsulfase.

El Dib RP, Pastores GM.

Biologics. 2009;3:459-68. Epub 2009 Oct 12.PMID: 19851471 [PubMed - in process]Related articlesFree article

Enzyme replacement therapy in mucopolysaccharidosis type I: progress and emerging difficulties.

Wraith JE.

J Inherit Metab Dis. 2001 Apr;24(2):245-50. Review.PMID: 11405343 [PubMed - indexed for MEDLINE]Related articles

[Mucopolysaccharidosis. A case report of Morquio's type-A disease (MPS IV-A)]

Pagni L, Bartolozzi L, Giacchetti D.

Minerva Stomatol. 1992 Nov;41(11):527-33. Italian. PMID: 1294876 [PubMed - indexed for MEDLINE]Related articles

[Enzyme replacement therapies for lysosomal storage disorders.]

Germain DP.

Med Sci (Paris). 2005 Dec;21(11 Suppl):77-83. French. PMID: 16324679 [PubMed - in process]Related articles

Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy.

Wraith JE, Scarpa M, Beck M, Bodamer OA, De Meirleir L, Guffon N, Meldgaard Lund A, Malm G, Van der Ploeg AT, Zeman J.

Eur J Pediatr. 2008 Mar;167(3):267-77. Epub 2007 Nov 23. Review.PMID: 18038146 [PubMed - indexed for MEDLINE]Related articlesFree article

Evaluation of heparin cofactor II-thrombin complex as a biomarker on blood spots from mucopolysaccharidosis I, IIIA and IIIB mice.

Langford-Smith K, Arasaradnam M, Wraith JE, Wynn R, Bigger BW.

Mol Genet Metab. 2010 Mar;99(3):269-74. Epub 2009 Oct 23.PMID: 19926322 [PubMed - in process]Related articles

Mucopolysaccharidoses in Brazil: what happens from birth to biochemical diagnosis?

Vieira T, Schwartz I, Muñoz V, Pinto L, Steiner C, Ribeiro M, Boy R, Ferraz V, de Paula A, Kim C, Acosta A, Giugliani R.

Am J Med Genet A. 2008 Jul 1;146A(13):1741-7.PMID: 18546277 [PubMed - indexed for MEDLINE]Related articles

Rheumatologists' recommendations on what to do in the dermatology office to evaluate and manage psoriasis patients' joint symptoms.

Taylor SL, Petrie M, O'Rourke KS, Feldman SR.

J Dermatolog Treat. 2009 Jan 1:1-4. [Epub ahead of print]PMID: 19322724 [PubMed - as supplied by publisher]Related articles

Outcome after three years of laronidase enzyme replacement therapy in a patient with Hurler syndrome.

Thomas JA, Jacobs S, Kierstein J, Van Hove J.

J Inherit Metab Dis. 2006 Dec;29(6):762. Epub 2006 Nov 6.PMID: 17089217 [PubMed - indexed for MEDLINE]Related articles

Clinical presentation and follow-up of patients with the attenuated phenotype of mucopolysaccharidosis type I.

Vijay S, Wraith JE.

Acta Paediatr. 2005 Jul;94(7):872-7.PMID: 16188808 [PubMed - indexed for MEDLINE]Related articles

Early onset of lysosomal storage disease in a murine model of mucopolysaccharidosis type VII: undegraded substrate accumulates in many tissues in the fetus and very young MPS VII mouse.

Vogler C, Levy B, Galvin N, Lessard M, Soper B, Barker J.

Pediatr Dev Pathol. 2005 Jul-Aug;8(4):453-62. Epub 2005 Oct 12.PMID: 16222480 [PubMed - indexed for MEDLINE]Related articles

Laronidase treatment of mucopolysaccharidosis I.

Wraith EJ, Hopwood JJ, Fuller M, Meikle PJ, Brooks DA.

BioDrugs. 2005;19(1):1-7. Review.PMID: 15691212 [PubMed - indexed for MEDLINE]Related articles

Japan Elaprase Treatment (JET) study: idursulfase enzyme replacement therapy in adult patients with attenuated Hunter syndrome (Mucopolysaccharidosis II, MPS II).

Okuyama T, Tanaka A, Suzuki Y, Ida H, Tanaka T, Cox GF, Eto Y, Orii T.

Mol Genet Metab. 2010 Jan;99(1):18-25. Epub .PMID: 19773189 [PubMed - in process]Related articles

Mucopolysaccharidosis type-IS presenting with onset of carpal tunnel syndrome at adolescence.

Bahadir C, Kurtulus D, Cihandide E.

J Clin Rheumatol. 2009 Dec;15(8):402-4.PMID: 19955999 [PubMed - in process]Related articles